CDGSH iron-sulfur domain 2 as a therapeutic target for stroke: an opinion article.
作者信息
Feng Chao-Kang, Chen Wei-Jung, Kung Woon-Man, Sun Yu-Yo, Lin Muh-Shi
机构信息
Department of Nursing, College of Nursing, Hung Kuang University, Taichung, Taiwan.
Department of Biotechnology and Animal Science, College of Bioresources, National Ilan University, Yilan, Taiwan.
出版信息
Front Mol Neurosci. 2024 May 28;17:1386118. doi: 10.3389/fnmol.2024.1386118. eCollection 2024.
Abstract
摘要
相似文献
1
CDGSH iron-sulfur domain 2 as a therapeutic target for stroke: an opinion article.
Front Mol Neurosci. 2024 May 28;17:1386118. doi: 10.3389/fnmol.2024.1386118. eCollection 2024.
2
Anti-Inflammatory CDGSH Iron-Sulfur Domain 2: A Biomarker of Central Nervous System Insult in Cellular, Animal Models and Patients.
Biomedicines. 2022 Mar 27;10(4):777. doi: 10.3390/biomedicines10040777.
3
The NFκB Antagonist CDGSH Iron-Sulfur Domain 2 Is a Promising Target for the Treatment of Neurodegenerative Diseases.
Int J Mol Sci. 2021 Jan 19;22(2):934. doi: 10.3390/ijms22020934.
4
CDGSH iron sulfur domain 2 mitigates apoptosis, oxidative stress and inflammatory response caused by oxygen-glucose deprivation/reoxygenation in HT22 hippocampal neurons by Akt-Nrf2-activated pathway.
Metab Brain Dis. 2022 Oct;37(7):2417-2429. doi: 10.1007/s11011-022-01043-z. Epub 2022 Jul 12.
5
CDGSH iron sulfur domain 2 over-expression alleviates neuronal ferroptosis and brain injury by inhibiting lipid peroxidation via AKT/mTOR pathway following intracerebral hemorrhage in mice.
J Neurochem. 2023 May;165(3):426-444. doi: 10.1111/jnc.15785. Epub 2023 Mar 8.
6
CDGSH Iron Sulfur Domain 2 Deficiency Inhibits Cell Proliferation and Induces Cell Differentiation of Neuroblastoma.
Pathol Oncol Res. 2020 Jul;26(3):1725-1733. doi: 10.1007/s12253-019-00753-7. Epub 2019 Oct 22.
7
Wild Bitter Melon Exerts Anti-Inflammatory Effects by Upregulating Injury-Attenuated CISD2 Expression following Spinal Cord Injury.
Behav Neurol. 2020 Sep 30;2020:1080521. doi: 10.1155/2020/1080521. eCollection 2020.
8
Upregulation of CDGSH iron sulfur domain 2 attenuates cerebral ischemia/reperfusion injury.
Neural Regen Res. 2023 Jul;18(7):1512-1520. doi: 10.4103/1673-5374.355766.
9
A novel prognostic score model incorporating CDGSH iron sulfur domain2 (CISD2) predicts risk of disease progression in laryngeal squamous cell carcinoma.
Oncotarget. 2016 Apr 19;7(16):22720-32. doi: 10.18632/oncotarget.8150.
10
Beneficial Impacts of Alpha-Eleostearic Acid from Wild Bitter Melon and Curcumin on Promotion of CDGSH Iron-Sulfur Domain 2: Therapeutic Roles in CNS Injuries and Diseases.
Int J Mol Sci. 2021 Mar 24;22(7):3289. doi: 10.3390/ijms22073289.
本文引用的文献
1
Upregulation of CDGSH iron sulfur domain 2 attenuates cerebral ischemia/reperfusion injury.
Neural Regen Res. 2023 Jul;18(7):1512-1520. doi: 10.4103/1673-5374.355766.
2
CDGSH iron sulfur domain 2 mitigates apoptosis, oxidative stress and inflammatory response caused by oxygen-glucose deprivation/reoxygenation in HT22 hippocampal neurons by Akt-Nrf2-activated pathway.
Metab Brain Dis. 2022 Oct;37(7):2417-2429. doi: 10.1007/s11011-022-01043-z. Epub 2022 Jul 12.
3
High Expression of CISD2 in Relation to Adverse Outcome and Abnormal Immune Cell Infiltration in Glioma.
Dis Markers. 2022 Apr 21;2022:8133505. doi: 10.1155/2022/8133505. eCollection 2022.
4
Anti-Inflammatory CDGSH Iron-Sulfur Domain 2: A Biomarker of Central Nervous System Insult in Cellular, Animal Models and Patients.
Biomedicines. 2022 Mar 27;10(4):777. doi: 10.3390/biomedicines10040777.
5
Beneficial Impacts of Alpha-Eleostearic Acid from Wild Bitter Melon and Curcumin on Promotion of CDGSH Iron-Sulfur Domain 2: Therapeutic Roles in CNS Injuries and Diseases.
Int J Mol Sci. 2021 Mar 24;22(7):3289. doi: 10.3390/ijms22073289.
6
Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction.
Front Oncol. 2021 Feb 1;10:595524. doi: 10.3389/fonc.2020.595524. eCollection 2020.
7
The NFκB Antagonist CDGSH Iron-Sulfur Domain 2 Is a Promising Target for the Treatment of Neurodegenerative Diseases.
Int J Mol Sci. 2021 Jan 19;22(2):934. doi: 10.3390/ijms22020934.
8
Ischemic stroke: A paradoxical manifestation of cancer.
Crit Rev Oncol Hematol. 2021 Jan;157:103181. doi: 10.1016/j.critrevonc.2020.103181. Epub 2020 Nov 16.
9
CISD2 Attenuates Inflammation and Regulates Microglia Polarization in EOC Microglial Cells-As a Potential Therapeutic Target for Neurodegenerative Dementia.
Front Aging Neurosci. 2020 Aug 26;12:260. doi: 10.3389/fnagi.2020.00260. eCollection 2020.
10
Protective Effects of CISD2 and Influence of Curcumin on CISD2 Expression in Aged Animals and Inflammatory Cell Model.
Nutrients. 2019 Mar 25;11(3):700. doi: 10.3390/nu11030700.
Zotero 插件